U.S. FDA To Open India Office In December
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - U.S. FDA plans to step up scrutiny of drugs and food made in India for the U.S. market by setting up offices next month in the country after establishing three branches in China, according to U.S. officials